The primary objective of this study is to evaluate the effects of a novel sunscreen formulation by assessing the extent of ultraviolet radiation (UVR)-induced direct and indirect cellular and DNA damage to human skin, in the presence vs absence of the sunscreen, in a population of healthy adults with fair skin (Fitzpatrick Scale type I, II or III).
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
DNA Damage Level by Cyclobutane Pyrimidine Dimer (CPD) Measurement
Timeframe: 5 minutes after UVR exposure
DNA Damage Level by Cyclobutane Pyrimidine Dimer (CPD) Measurement
Timeframe: 4 hours after UVR exposure
Detectable DNA Strand Breaks
Timeframe: 5 minutes after UVR exposure
Number of DNA Strand Breaks
Timeframe: 4 hours after UVR exposure
Cellular Damage
Timeframe: 5 minutes after UVR exposure
Cellular Damage
Timeframe: 4 hours after UVR exposure